General Information

Mail: University of Houston
Cullen College of Engineering
E421 Engineering Bldg 2, Houston, TX 77204-4007
Map & Driving Directions (includes parking information)
Email: info [at] egr [dot] uh [dot] edu

News

ChBE's Michael Economides Writes The Hill's Congress Blog: "The President's Legacy on Energy"

Printer-friendly versionSend by emailPDF version

By: 

Audrey Grayson

Professor Michael Economides in the UH Cullen College of Engineering's department of chemical and biomolecular engineering contributed an article titled "The president's legacy on energy" to The Hill's Congress Blog, published on May 22.

If the name Michael Economides sounds familiar to you, it's because it probably is. Although Economides is known to his students in the chemical and biomolecular engineering department as an outstanding educator and mentor, he is known around the world as a leading energy analyst, consultant, educator, author and petroleum engineer.

In addition to his role as professor at the UH Cullen College of Engineering, he is a managing partner of a petroleum engineering consulting firm and the editor-in-chief of the Energy Tribune. He has authored or co-authored 15 professional textbooks and books, including “The Color Of Oil” and over 300 journal papers and articles. Economides -- widely revered as a premiere expert on the geopolitics of energy -- is a regular guest on national and international media as well as a regular contributer in the editorial pages of newspapers and magazines.

Read his article at The Hill's Congress Blog: http://thehill.com/blogs/congress-blog/energy-a-environment/301411-the-presidents-legacy-on-energy.

Visit Professor Michael Economides Twitter: https://twitter.com/MJEconomides.

 

 

Department: 

Related News Stories

Researcher Publishes Paper on Engineered Antibody that Targets Acute Myeloid Leukemia

Almost 19,000 new cases of acute myeloid leukemia and 10,500 deaths from the blood and bone marrow cancer could strike Americans this year, according to the American Cancer Society. Chemotherapy, when used as primary treatment, is successful in about 65 percent of patients with the cancer, and remission rates vary depending on patients’ individual characteristics, according to the organization.

Upcoming Events / Seminars

Archived News